Physician profile
Matthew Vincent Brumm
NPI 1154500726
$1,507.98
in general payments reported to CMS, 2019-2025
18 companies · $185 in 2025
The $185 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $639 · 2020: $45.27 · 2021: $127 · 2022: $165 · 2023: $152 · 2024: $195 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $531.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $531.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $370.45 | 2019-2025 | Tecnis Iol, Tecnis Iol, Tecnis Simplicity |
| Abbvie INC. | $312.66 | 2022-2025 | Lumigan, Alphagan P, Vuity |
| Glaukos Corporation | $181.61 | 2019 | |
| Novartis Pharmaceuticals Corporation | $146.99 | 2019 | |
| The Cameron-Ehlen Group, INC. | $82.75 | 2019-2022 | |
| Oyster Point Pharma, INC. | $62.06 | 2022-2024 | Tyrvaya |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $60.98 | 2021 | |
| Sun Pharmaceutical Industries INC. | $47.58 | 2019-2024 | |
| Biotissue Holdings INC. | $42.33 | 2022-2024 | |
| Align Ophthalmics LLC | $37.10 | 2024 | |
| Rayner Intraocular Lenses Limited | $32.25 | 2023 | Rayone Spheric, Rayone Emv, Rayone Aspheric |
| Aerie Pharmaceuticals, INC. | $29.75 | 2019-2021 | |
| Alcon Vision LLC | $19.59 | 2025 | Hydrus Microstent |
| Optos, INC. | $19.41 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $18.27 | 2025 | Vabysmo |
| Allergan, INC. | $13.15 | 2021 | |
| Shire North American Group INC | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Brumm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.